These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7420469)

  • 1. Studies of the molecular pathogenesis of hexane neuropathy. I. evaluation of the inhibition of glyceraldehyde-3-phosphate dehydrogenase by 2,5-hexanedione.
    Graham DG; Abou-Donia MB
    J Toxicol Environ Health; 1980 May; 6(3):621-31. PubMed ID: 7420469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo studies of the molecular pathogenesis of n-Hexane neuropathy.
    Graham DG; Anthony DC; Boekelheide K
    Neurobehav Toxicol Teratol; 1982; 4(6):629-34. PubMed ID: 7170020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexane neuropathy: a proposal for pathogenesis of a hazard of occupational exposure and inhalant abuse.
    Graham DG
    Chem Biol Interact; 1980 Nov; 32(3):339-45. PubMed ID: 7191786
    [No Abstract]   [Full Text] [Related]  

  • 4. Further observations on in vitro and in vivo effects of 2,5-hexanedione on glyceraldehyde-3-phosphate dehydrogenase.
    Sabri MI
    Arch Toxicol; 1984 Sep; 55(3):191-4. PubMed ID: 6497651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the inhibition of glycolytic enzymes by the neurotoxicant dimethylaminopropionitrile.
    Froines JR; Watson AJ
    J Toxicol Environ Health; 1985; 16(3-4):469-79. PubMed ID: 2935639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of glyceraldehyde-3-phosphate dehydrogenase with SH-reagents and its relationship to the protein quaternary structure.
    Malhotra OP; Srivastava DK; Kayastha AM; Srinivasan
    Indian J Biochem Biophys; 1993 Oct; 30(5):264-9. PubMed ID: 8144169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure.
    Castilho MS; Pavão F; Oliva G; Ladame S; Willson M; Périé J
    Biochemistry; 2003 Jun; 42(23):7143-51. PubMed ID: 12795610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite.
    Souza JM; Radi R
    Arch Biochem Biophys; 1998 Dec; 360(2):187-94. PubMed ID: 9851830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glyceraldehyde-3-phosphate dehydrogenase in tissues of the rat by acrylamide and related compounds.
    Vyas I; Lowndes HE; Howland RD
    Neurotoxicology; 1985; 6(3):123-32. PubMed ID: 4047509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies.
    Guido RV; Oliva G; Montanari CA; Andricopulo AD
    J Chem Inf Model; 2008 Apr; 48(4):918-29. PubMed ID: 18303835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of n-hexane and its metabolites on selected enzymes in glycolysis, pentose phosphate pathway and citric acid cycle.
    Sabri MI
    Brain Res; 1984 Apr; 297(1):145-50. PubMed ID: 6232975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous nitric oxide (NO) generation or IL-1 beta-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells.
    Dimmeler S; Ankarcrona M; Nicotera P; Brüne B
    J Immunol; 1993 Apr; 150(7):2964-71. PubMed ID: 8454867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sulfhydryl modification reagents on the kinase activity of the epidermal growth factor receptor.
    Woltjer RL; Staros JV
    Biochemistry; 1997 Aug; 36(32):9911-6. PubMed ID: 9245424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein S-thiolation targets glycolysis and protein synthesis in response to oxidative stress in the yeast Saccharomyces cerevisiae.
    Shenton D; Grant CM
    Biochem J; 2003 Sep; 374(Pt 2):513-9. PubMed ID: 12755685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of modification of SH-groups in D-glyceraldehyde-3-phosphate dehydrogenase on the properties of enzyme--coenzyme complex.
    Vas M; Bartha F
    Acta Biochim Biophys Acad Sci Hung; 1976; 11(2-3):95-104. PubMed ID: 188295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glyceraldehyde-3-phosphate dehydrogenase activity by antibodies present in the cerebrospinal fluid of patients with multiple sclerosis.
    Kölln J; Zhang Y; Thai G; Demetriou M; Hermanowicz N; Duquette P; van den Noort S; Qin Y
    J Immunol; 2010 Aug; 185(3):1968-75. PubMed ID: 20610654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol.
    Gregus Z; Németi B
    Toxicol Sci; 2005 Jun; 85(2):859-69. PubMed ID: 15788719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide.
    Dietze EC; Schäfer A; Omichinski JG; Nelson SD
    Chem Res Toxicol; 1997 Oct; 10(10):1097-103. PubMed ID: 9348431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of an enzyme in crude cell extracts. The use of subunits modified with a half-of-the-sites reagent.
    Muronetz VI; Ashmarina LI; Nagradova NK
    Biochem Int; 1983 Apr; 6(4):443-50. PubMed ID: 6385975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of D-glyceraldehyde-3-phosphate dehydrogenase by ATP and quinaldate.
    Lien LV; Keleti T
    Acta Biochim Biophys Acad Sci Hung; 1979; 14(1-2):1-9. PubMed ID: 517104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.